Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cholesterol 24-hydroxylase (CH24H / CYP46A1) is a cytochrome P450 enzyme primarily expressed in the brain, where it plays a crucial role in cholesterol homeostasis. It catalyzes the hydroxylation of cholesterol to 24S-hydroxycholesterol, facilitating cholesterol export from the brain. 24S-hydroxycholesterol also acts as an LXR agonist, influencing lipid metabolism. CH24H is a therapeutic target for neurological disorders, with inhibitors like Soticlestat being developed.
Inhibition of cholesterol 24-hydroxylation
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cholesterol 24-hydroxylase (CH24H).